$AEHR

SPORCK ALISTAIR N sold $108K of AEHR

SPORCK ALISTAIR N (VP Contactor Business Unit) sold 1,000 shares of AEHR TEST SYSTEMS (AEHR) at $108.49 ($0.11M total) on 2026-08-10.

Original reporting
SEC EDGAR · SPORCK ALISTAIR N
Published Aug 11, 2026, 6:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The newest fact is the specific open-market sale: 1,000 shares at $108.49 on 2026-08-10, with holdings after the sale of 22,547 shares.

02

Market read

Traders may note the insider sale for sentiment, but the transaction size and lack of company-specific news limit trading impact.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, so this should not be treated as a directional earnings signal without corroborating fundamentals.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-11, transaction dated 2026-08-10

Background

This is an SEC Form 4 insider transaction for AEHR Test Systems, reported by VP AlistaIr N Sporck.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR insider Form 4 shows VP AlistaIr N Sporck sold 1,000 shares on 2026-08-10 at $108.49, worth about $108.5K.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades quickly.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the transaction size is small relative to typical AEHR trading and lacks accompanying company-specific catalysts.

Market effects

No clear read-through to the medical device or test systems sector from a single small insider sale.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as less systematic selling, but the disclosed value is still modest.

Key entities

  • AEHR Test Systems

    Company subject of the Form 4 insider transaction disclosure.

  • SPORCK ALISTAIR N

    VP, Contactor Business Unit, who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRMed

AEHR Stock Rides AI Order Wave Amid Volatility

Aehr Test Systems (AEHR) stock rose 13.28% following strong earnings and a positive outlook for semiconductor test demand. The company reported $50M in revenue, $18.8M in quarterly revenue, and a net income of $1.39M. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI production. The stock has shown volatility, with a recent drop of 9.5-10.5% in a single session. Insiders have sold shares but maintain significant holdings. AEHR is actively presenting a

$AEHRHigh

AEHR Stock Rallies As AI Orders And Wall Street Support Build

Aehr Test Systems (AEHR) stock rose 11.71% due to strong AI-related demand. The company reported $18.8M in revenue with a 35.3% gross margin. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI chip production. The company has a strong balance sheet and a $22M follow-on order from a major customer.

$AEHRHigh

AEHR Stock Rallies As AI Test Orders And Wall Street Support Grow

Aehr Test Systems (NASDAQ: AEHR) stock rose 11.73% on growing AI test demand. The company secured a $22M follow-on order for AI chip testing equipment. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's unique position in AI production testing. The stock has high volatility, with a strong balance sheet but negative EBIT margins.